Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartan Medoxomil Tablets 40 mg; Drug: Daiichi Sankyo Inc's Benicar Tablets 40 mg Sponsor: Torrent Pharmaceuticals Limited Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2017 Category: Research Source Type: clinical trials